GlassScriptPhysician profile
Leslie Pahl
NPI 1184223034
$2,360.14
in general payments reported to CMS, 2019-2025
15 companies · $181 in 2025
The $181 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $34.06 · 2022: $519 · 2023: $1,387 · 2024: $239 · 2025: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,807.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,807.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $457.19 | 2022-2023 | |
| Stryker Corporation | $446.31 | 2023-2024 | Everest Spinal System, Cascadia Interbody System, Tritanium |
| Janssen Pharmaceuticals, INC | $432.26 | 2022-2023 | Xarelto |
| C. R. Bard, INC. & Subsidiaries | $163.65 | 2023 | Arista Ah Flexitip |
| Globus Medical, INC. | $155.87 | 2025 | Excelsius Gps |
| Astrazeneca Pharmaceuticals LP | $126.14 | 2023 | Andexxa |
| Relievant Medsystems, INC. | $123.31 | 2022-2023 | Intracept |
| Ucb, INC. | $122.79 | 2021-2022 | |
| Sk Life Science, INC. | $105.58 | 2023 | Xcopri |
| Depuy Synthes Sales INC. | $58.18 | 2024-2025 | Matrixneuro |
| Mml US, INC. | $54.60 | 2023 | Reactiv8 |
| Averitas Pharma INC. | $54.02 | 2023-2024 | Qutenza |
| Spr Therapeutics, INC | $27.65 | 2023 | Sprint Pns System |
| Boston Scientific Corporation | $16.63 | 2024 | Intracept |
| Ethicon US, LLC | $15.96 | 2024 | Surgicel Nu-Knit, Stratafix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leslie Pahl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.